サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412272

遺伝子増幅技術市場：技術、製品タイプ、サンプルタイプ、エンドユーザー別-2024-2030年の世界予測

Gene Amplification Technologies Market by Technology, Product, Sample Type, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
遺伝子増幅技術市場：技術、製品タイプ、サンプルタイプ、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子増幅技術市場規模は2023年に267億5,000万米ドルと推計され、2024年には279億1,000万米ドルに達し、CAGR 4.41%で2030年には362億米ドルに達すると予測されます。

遺伝子増幅技術の世界市場

主な市場の統計
基準年[2023］ 267億5,000万米ドル
予測年[2024] 279億1,000万米ドル
予測年 [2030] 362億米ドル
CAGR（%） 4.41%
遺伝子増幅技術 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは遺伝子増幅技術市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、遺伝子増幅技術市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-遺伝子増幅技術市場の市場規模および予測は？

2-遺伝子増幅技術市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-遺伝子増幅技術市場における技術動向と規制の枠組みは？

4-遺伝子増幅技術市場における主要ベンダーの市場シェアは？

5-遺伝子増幅技術市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 先進的なDNA増殖技術の大幅な拡大
      • ゲノミクスおよび分子診断分野における継続的な研究開発活動
      • 慢性疾患に対する個別化医療のニーズの高まり
    • 抑制要因
      • 技術の複雑さとPCR機器のコストの高さ
    • 機会
      • 次世代遺伝子増幅技術のイントロダクション
      • 細胞治療および遺伝子治療における新たな発展
    • 課題
      • 熟練した経験豊富な主題の専門家が不足している
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 遺伝子増幅技術市場：技術別

  • ループ媒介等温増幅
  • 核酸配列に基づく増幅
  • PCRベースの増幅
  • 逆転写
  • ローリングサークル増幅

第7章 遺伝子増幅技術市場：製品別

  • 機器と装置
  • 試薬と消耗品
  • ソフトウェアとサービス

第8章 遺伝子増幅技術市場サンプルタイプ別

  • 血
  • 細胞株
  • 環境
  • 病原体
  • 組織

第9章 遺伝子増幅技術市場：エンドユーザー別

  • 受託調査機関
  • 法医学研究所
  • 病院と診断センター
  • 製薬会社
  • 調査機関

第10章 南北アメリカの遺伝子増幅技術市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の遺伝子増幅技術市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの遺伝子増幅技術市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 4basebio AG
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • Ambion Inc.
    • Bayer Pharmaceutics AG
    • Becton Dickinson and Co.
    • Bio-Rad Laboratories
    • bioMerieux SA
    • Cepheid
    • Danaher Corporation
    • Digene Corporation
    • F. Hoffmann-La Roche Ltd.
    • Genentech, Inc.
    • Illumina Inc.
    • LGC Group
    • Menarini Silicon Biosystems SpA
    • Merck KGaA
    • MyBioSource, Inc.
    • Nanjing Vazyme Biotech Co.,Ltd.
    • New England Biolabs, Inc.
    • PerkinElmer Inc.
    • Promega Corporation
    • Qiagen N.V.
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. GENE AMPLIFICATION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GENE AMPLIFICATION TECHNOLOGIES MARKET DYNAMICS
  • FIGURE 7. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 10. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. GENE AMPLIFICATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. GENE AMPLIFICATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. GENE AMPLIFICATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PCR-BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PATHOGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. GENE AMPLIFICATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 196. GENE AMPLIFICATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. GENE AMPLIFICATION TECHNOLOGIES MARKET LICENSE & PRICING
目次
Product Code: MRR-FF012EDC38D6

[199 Pages Report] The Gene Amplification Technologies Market size was estimated at USD 26.75 billion in 2023 and expected to reach USD 27.91 billion in 2024, at a CAGR 4.41% to reach USD 36.20 billion by 2030.

Global Gene Amplification Technologies Market

KEY MARKET STATISTICS
Base Year [2023] USD 26.75 billion
Estimated Year [2024] USD 27.91 billion
Forecast Year [2030] USD 36.20 billion
CAGR (%) 4.41%
Gene Amplification Technologies Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gene Amplification Technologies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Amplification Technologies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Amplification Technologies Market, highlighting leading vendors and their innovative profiles. These include 4basebio AG, Abbott Laboratories, Agilent Technologies, Inc., Ambion Inc., Bayer Pharmaceutics AG, Becton Dickinson and Co., Bio-Rad Laboratories, bioMerieux SA, Cepheid, Danaher Corporation, Digene Corporation, F. Hoffmann-La Roche Ltd., Genentech, Inc., Illumina Inc., LGC Group, Menarini Silicon Biosystems SpA, Merck KGaA, MyBioSource, Inc., Nanjing Vazyme Biotech Co.,Ltd., New England Biolabs, Inc., PerkinElmer Inc., Promega Corporation, Qiagen N.V., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Amplification Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Loop-mediated Isothermal Amplification
    • Nucleic Acid Sequence Based Amplification
    • PCR-based Amplification
    • Reverse Transcription
    • Rolling Circle Amplification
  • Product
    • Instruments & Equipment
    • Reagents & Consumables
    • Software & Services
  • Sample Type
    • Blood
    • Cell Lines
    • Environmental
    • Pathogen
    • Tissue
  • End-User
    • Contract Research Organizations
    • Forensic Labs
    • Hospitals & Diagnostic Centers
    • Pharmaceutical Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Gene Amplification Technologies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Amplification Technologies Market?

3. What are the technology trends and regulatory frameworks in the Gene Amplification Technologies Market?

4. What is the market share of the leading vendors in the Gene Amplification Technologies Market?

5. Which modes and strategic moves are suitable for entering the Gene Amplification Technologies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Gene Amplification Technologies Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant expansion of advanced DNA multiplication technologies
      • 5.1.1.2. Ongoing R&D activities for genomics and molecular diagnostics arena
      • 5.1.1.3. Growing need for the personalized medicines for chronic conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Technology complications and high cost of PCR instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of next-generation technologies for gene amplification
      • 5.1.3.2. Emerging developments in cell and gene therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled and experienced subject experts
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Gene Amplification Technologies Market, by Technology

  • 6.1. Introduction
  • 6.2. Loop-mediated Isothermal Amplification
  • 6.3. Nucleic Acid Sequence Based Amplification
  • 6.4. PCR-based Amplification
  • 6.5. Reverse Transcription
  • 6.6. Rolling Circle Amplification

7. Gene Amplification Technologies Market, by Product

  • 7.1. Introduction
  • 7.2. Instruments & Equipment
  • 7.3. Reagents & Consumables
  • 7.4. Software & Services

8. Gene Amplification Technologies Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Cell Lines
  • 8.4. Environmental
  • 8.5. Pathogen
  • 8.6. Tissue

9. Gene Amplification Technologies Market, by End-User

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Forensic Labs
  • 9.4. Hospitals & Diagnostic Centers
  • 9.5. Pharmaceutical Companies
  • 9.6. Research Institutes

10. Americas Gene Amplification Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gene Amplification Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gene Amplification Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. 4basebio AG
    • 14.1.2. Abbott Laboratories
    • 14.1.3. Agilent Technologies, Inc.
    • 14.1.4. Ambion Inc.
    • 14.1.5. Bayer Pharmaceutics AG
    • 14.1.6. Becton Dickinson and Co.
    • 14.1.7. Bio-Rad Laboratories
    • 14.1.8. bioMerieux SA
    • 14.1.9. Cepheid
    • 14.1.10. Danaher Corporation
    • 14.1.11. Digene Corporation
    • 14.1.12. F. Hoffmann-La Roche Ltd.
    • 14.1.13. Genentech, Inc.
    • 14.1.14. Illumina Inc.
    • 14.1.15. LGC Group
    • 14.1.16. Menarini Silicon Biosystems SpA
    • 14.1.17. Merck KGaA
    • 14.1.18. MyBioSource, Inc.
    • 14.1.19. Nanjing Vazyme Biotech Co.,Ltd.
    • 14.1.20. New England Biolabs, Inc.
    • 14.1.21. PerkinElmer Inc.
    • 14.1.22. Promega Corporation
    • 14.1.23. Qiagen N.V.
    • 14.1.24. Takara Bio Inc.
    • 14.1.25. Thermo Fisher Scientific Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing